NuWays initiates Gallmetzer HealthCare with Buy, sets target at EUR 4.4

NuWays initiated coverage of Gallmetzer Healthcare with a BUY rating, setting a 12-month target price of EUR 4.4. The thesis centers on organic growth and margin expansion from a vertically integrated dental platform.